- Home
- KMT vs NVCR Comparison
KMT vs NVCR Comparison
Compare KMT & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMT
- NVCR
- Stock Information
- Founded
- KMT 1938
- NVCR 2000
- Country
- KMT United States
- NVCR Switzerland
- Employees
- KMT N/A
- NVCR N/A
- Industry
- KMT Industrial Machinery/Components
- NVCR Medical/Dental Instruments
- Sector
- KMT Industrials
- NVCR Health Care
- Exchange
- KMT Nasdaq
- NVCR Nasdaq
- Market Cap
- KMT 1.6B
- NVCR 1.9B
- IPO Year
- KMT N/A
- NVCR 2015
- Fundamental
- Price
- KMT $24.71
- NVCR $17.60
- Analyst Decision
- KMT Hold
- NVCR Buy
- Analyst Count
- KMT 5
- NVCR 7
- Target Price
- KMT $25.40
- NVCR $32.43
- AVG Volume (30 Days)
- KMT 1.2M
- NVCR 1.3M
- Earning Date
- KMT 08-06-2025
- NVCR 07-24-2025
- Dividend Yield
- KMT 3.23%
- NVCR N/A
- EPS Growth
- KMT 2.33
- NVCR N/A
- EPS
- KMT 1.38
- NVCR N/A
- Revenue
- KMT $1,993,706,000.00
- NVCR $621,711,000.00
- Revenue This Year
- KMT N/A
- NVCR $5.56
- Revenue Next Year
- KMT $1.80
- NVCR $9.19
- P/E Ratio
- KMT $17.86
- NVCR N/A
- Revenue Growth
- KMT N/A
- NVCR 18.27
- 52 Week Low
- KMT $17.30
- NVCR $14.17
- 52 Week High
- KMT $32.18
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- KMT 69.54
- NVCR 49.74
- Support Level
- KMT $23.54
- NVCR $16.81
- Resistance Level
- KMT $24.95
- NVCR $18.59
- Average True Range (ATR)
- KMT 0.59
- NVCR 0.74
- MACD
- KMT 0.13
- NVCR 0.08
- Stochastic Oscillator
- KMT 93.24
- NVCR 56.18
About KMT Kennametal Inc.
Kennametal Inc is a manufacturer of metalworking tools and wear-resistant engineered components and coatings. The company operates in two business segments; Metal Cutting and Infrastructure. It generates maximum revenue from the Metal Cutting segment. The Metal Cutting segment develops and manufactures high-performance tooling and metal cutting products and services and offers an assortment of standard and custom metal cutting solutions to diverse end markets, including aerospace, general engineering, energy, and transportation. Geographically, it derives maximum revenue from the United States and the rest from Germany, China, Canada, India, Italy, and other countries.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.